# Ocular Changes With Alpha-2 Receptor Agonist.

> **NCT05670015** · NA · UNKNOWN · sponsor: **Benha University** · enrollment: 150 (estimated)

## Conditions studied

- Glaucoma, Suspect
- Aberration, Corneal Wavefront

## Interventions

- **DRUG:** Low dosage selective alpha-2 receptor agonists topical eyedrop
- **DRUG:** High dosage selective alpha-2 receptor agonists topical eyedrop

## Key facts

- **NCT ID:** NCT05670015
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2023-08-10
- **Final completion:** 2023-09-22
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05670015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05670015, "Ocular Changes With Alpha-2 Receptor Agonist.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05670015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*